Exact Sciences | EXAS - Ebitda


Exact Sciences reported $138.22M in EBITDA for its fiscal quarter ending in June of 2025.



Financials
Stock Price USD
Assets USD 5.8B
Cash and Equivalent USD 657.1M
Cost of Sales USD 248.63M
Current Assets USD 1.51B
Current Liabilities USD 521.93M
Debt USD 2.32B
EBIT USD -2.15M
EBITDA USD 138.22M
Employees 6.9K
EPS Earnings Per Share USD -0.01
Equity Capital and Reserves USD 2.47B
Gross Profit on Sales USD 562.45M
Interest Expense on Debt USD 9.84M
Interest Income USD -5.29
Loan Capital USD 2.32B
Market Capitalization USD 9.96B
Net Income USD -1.19M
Operating Expenses USD 813.23M
Operating Profit USD -2.15M
Ordinary Share Capital USD 189.22M
Pre-Tax Profit USD -57K
Sales Revenues USD 811.1M
Selling and Administration Expenses USD 455.7M
Stock USD 171.5M
Trade Creditors USD 157.32M
Trade Debtors USD 353.34M

Ebitda Change Date
Agilent USD 466M 14M Jul/2025
Becton, Dickinson and Co. USD 1.47B 81M Jun/2025
Bio Techne USD 115.58M 47.73M Jun/2025
Bio-Rad Laboratories USD 467.2M 372.2M Jun/2025
Bruker USD 128.1M 27.1M Jun/2025
Charles River Laboratories USD 220.89M 2.01M Jun/2025
Danaher USD 1.34B 543M Jun/2025
Exact Sciences USD 138.22M 173.88M Jun/2025
Hologic USD 334M 26.7M Jun/2025
Illumina USD 399M 168M Jun/2025
Mettler Toledo International USD 295.89M 43.87M Jun/2025
Myriad Genetics USD -17800000 15.7M Mar/2025
Quidel USD 106.8M 33.8M Jun/2025
Repligen USD 32.18M 9.36M Jun/2025
Revvity USD 209.29M 22.24M Jun/2025
STAAR Surgical USD -14939000 17.46M Jun/2025
Thermo Fisher Scientific USD 3.06B 541M Jun/2025
Veracyte USD 35.78M 29.25M Jun/2025
Waters USD 276.28M 74.81M Jun/2025